Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda PharmaceuticalfiledCriticalTakeda Pharmaceutical
Priority to UY0001032191ApriorityCriticalpatent/UY32191A/en
Publication of UY32191ApublicationCriticalpatent/UY32191A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención apunta a proveer un compuesto que tiene una acción selectiva superior como antagonista del receptor adrnérgic alfa 1 D y es útil para la profilaxis o el tratamiento de una enfermedad de tracto urinario inferior y similares. La presente invención provee un compuesto representado por la fórmula (I) en la cual cada símbolo es como se definió en la memoria descriptiva, o una de sus sales.The present invention aims to provide a compound that has a superior selective action as an antagonist of the alpha 1 D adrnergic receptor and is useful for the prophylaxis or treatment of a lower urinary tract disease and the like. The present invention provides a compound represented by the formula (I) in which each symbol is as defined in the specification, or one of its salts.
UY0001032191A2009-10-212009-10-21
IMINOPIRIDINE DERIVATIVES AND USE OF THE SAME
UY32191A
(en)
Compounds derived from pyrazinooxazepine, serotonin receptor 5-ht2c activator, pharmaceutical composition comprising them; and its use in the treatment and / or prophylaxis of lower urinary tract symptoms, obesity and / or organ prolapse.